Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine Cohort, France, 1985–1997

Journal of the American College of Nutrition

Volumn 20, Issue 6, 2001, Pages 609-615

  Malvy, Denis ^a,b   Thiébaut, Rodolphe ^a   Marimoutou, Catherine ^a   Dabis, François ^a  

^a INSERM   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Acquired immunodeficiency syndrome; Body mass index; Disease progression; HIV infection; Weight loss

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; RISK FACTOR; SAMPLE; STATISTICAL MODEL; TIME; WEIGHT REDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0035661515     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2001.10719065     Document Type: Article

References (35)

1. Suttmann U, Ockenga J, Hoogestraat L, Selberg O, Schedel I, Deicher H, Muller MJ: Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients. Metabolism 42: 1173-1179, 1993.
2. Coodley GO, Loveless MO, Nelson HD, Coodley MK: Endocrine function in the HIV wasting syndrome. J Acquir Immune Defic Syndr 7: 46-51, 1994.
3. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ, Griffin GE: Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 333: 83-88, 1995.
4. Mulligan K, Tai VW, Schambelan M: Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 15: 43-48, 1997.
5. Palenicek JP, Graham NM, He YD, Hoover DA, Oishi JS, Kingsley L, Saah AJ: Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol 10: 366-373, 1995.
6. Kotler DP, Tierney AR, Wang J, Pierson RN: Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50: 444-447, 1989.
7. Hoover DR, Saah A, Bacellar H, Murphy R, Visscher B, Metz S, Anderson R, Kaslow RA: The progression of untreated HIV-1 infection prior to AIDS. Am J Public Health 82: 1538-1541, 1992.
8. Clark RA, Blakley SA, Rice J, Brandon W: Predictors of HIV disease progression in women. J Acquir Immune Defic Syndr Hum Retrovirol 9: 43-50, 1995.
9. Vella S, Floridia M, Giuliano M, Pezzotti P, Agresti MG, Chiesi A: Progression to AIDS and predictors of disease progression in a cohort of 859 zidovudine-treated ARC patients: a study comparing homosexuals and I.V. drug users. Int Conf AIDS 7: 33 [Abstract No. W.C.44], 1991.
10. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, Abrams DI, Bartsch GE: Weight loss as a predictor of survival and disease progression in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 18: 80-85, 1998.
11. Marimoutou C, Chene G, Dabis F, Lacoste D, Salamon R: Human immunodeficiency virus infection and AIDS in Aquitaine. 10 years’ experience of a hospital information system, 1985-1995. Le Groupe d’Epidemiologie Clinique du SIDA en Aquitaine (GECSA) [in French]. Presse Méd 26: 703-710, 1997.
12. Réseau National de Santé Publique: Révision de la définition du SIDA en France. Bull Epidem Heb: 1-2, 1993.
13. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41: 1-19, 1992.
14. Brookmeyer R, Gail MH, Polk BF: The prevalent cohort study and the acquired immunodeficiency syndrome. Am J Epidemiol 126: 14-24, 1987.
15. Alcabes P, Pezzotti P, Phillips AN, Rezza G, Vlahov D: Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. Am J Epidemiol 146: 543-551, 1997.
16. Rosenberg PS, Goedert JJ, Biggar RJ: Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters. AIDS 8: 803-810, 1994.
17. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GCD, Drummond JE, Vaidya K, Mann DL, Eyster ME, et al.: A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 321: 1141-1148, 1989.
18. Sorkin JD, Bolton PA, Greenblatt J, Sithisarankul P, Vlahov D, Graham NM: Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. Epidemiology 6: 172-177, 1995.
19. Graham NM, Zeger SL, Park LP, Phair JP, Detels R, Vermund SH, Ho M, Saah AJ: Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet 338: 265-269, 1991.
20. The Italian Seroconversion Study: Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study. AIDS 6: 421-426, 1992.
21. Hoover DR, Rinaldo C, He Y, Phair J, Fahey J, Graham NM: Long-term survival without clinical AIDS after CD4 cell counts fall below 200 10(6)/1. AIDS 9: 145-152, 1995.
22. Morlat P, Parneix P, Douard D, Lacoste D, Dupon M, Chene G, Pellegrin JL, Ragnaud JM, Dabis F: Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. AIDS 6: 1187-1193, 1992.
23. Munoz A, Vlahov D, Solomon L, Margolick JB, Bareta JC, Cohn S, Astemborski J, Nelson KE: Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr 5: 694-700, 1992.
24. Centers for Disease Control: Revision of CDC surveillance case definition for acquired immune deficiency syndrome. MMWR 36: 1S-15S, 1987.
25. Niyongabo T, Bouchaud O, Henzel D, Melchior JC, Samb B, Dazza MC, Ruggeri C, Begue JC, Coulaud JP, Larouze B: Nutritional status of HIV-seropositive subjects in an AIDS clinic in Paris. Eur J Clin Nutr 51: 637-640, 1997.
26. O’Sullivan P, Linke RA, Dalton S: Evaluation of body weight and nutritional status among AIDS patients. J Am Diet Assoc 85: 1483-1484, 1985.
27. Ysseldyke LL: Nutritional complications and incidence of malnutrition among AIDS patients. J Am Diet Assoc 91: 217-218, 1991.
28. Graham NM, Rubb S, Hoover DR, McCall LD, Palenicek JG, Saah AJ: Beta 2-microglobulin and other early predictors of human immunodeficiency virus type 1-related wasting. Ann Epidemiol 4: 32-39, 1994.
29. Schwenk A, Buger B, Wessel D, Stutzer H, Ziegenhagen D, Diehi V, Schrappe M: Clinical risk factors for malnutrition in HIV-1-infected patients. AIDS 7: 1213-1219, 1993.
30. Ferro-Luzzi A, Sette S, Franklin M, James WP: A simplified approach of assessing adult chronic energy deficiency. Eur J Clin Nutr 46: 173-186, 1992.
31. Hogg RS, Zadra JN, Chan-Yan C, Voigt R, Craib KJ, Korosi-Ronco J, Montaner JS, Schechter MT: Analysis of nutritional intake in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 9: 162-167, 1995.
32. Report of a WHO Expert Committee. “Physical Status: The Use and Interpretation of Anthropometry”. WHO Technical Report Series. Geneva: Vol. 854, 1995.
33. Nieman RB, Fleming J, Coker RJ, Harris JR, Mitchell DM: The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS 7: 705-710, 1993.
34. Sharkey SJ, Sharkey KA, Sutherland LR, Church DL: Nutritional status and food intake in human immunodeficiency virus infection. GI/HIV Study Group. J Acquir Immune Defic Syndr 5: 1091-1098, 1992.
35. Graham NM, Munoz A, Bacellar H, Kingsley LA, Visscher BR, Phair JP: Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the Multicenter AIDS Cohort Study. Am J Epidemiol 137: 439-446, 1993.